Stericycle Inc. (SRCL) Shares Sold by IBM Retirement Fund
IBM Retirement Fund lowered its position in shares of Stericycle Inc. (NASDAQ:SRCL) by 17.1% during the second quarter, Holdings Channel reports. The institutional investor owned 8,329 shares of the company’s stock after selling 1,718 shares during the period. IBM Retirement Fund’s holdings in Stericycle were worth $867,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently bought and sold shares of SRCL. Balentine LLC increased its position in Stericycle by 34.9% in the first quarter. Balentine LLC now owns 1,064 shares of the company’s stock worth $134,000 after buying an additional 275 shares in the last quarter. Canada Pension Plan Investment Board increased its position in Stericycle by 54.1% in the first quarter. Canada Pension Plan Investment Board now owns 1,415 shares of the company’s stock worth $179,000 after buying an additional 497 shares in the last quarter. Trust Co. of Vermont increased its position in Stericycle by 70.9% in the second quarter. Trust Co. of Vermont now owns 1,784 shares of the company’s stock worth $186,000 after buying an additional 740 shares in the last quarter. Jones Financial Companies Lllp bought a new position in Stericycle during the first quarter worth approximately $203,000. Finally, Charter Trust Co. bought a new position in Stericycle during the second quarter worth approximately $203,000. 92.81% of the stock is owned by institutional investors.
Stericycle Inc. (NASDAQ:SRCL) traded down 0.64% during trading on Friday, hitting $81.24. The stock had a trading volume of 1,818,195 shares. Stericycle Inc. has a 52 week low of $80.73 and a 52 week high of $151.57. The company’s 50-day moving average is $87.43 and its 200 day moving average is $103.72. The firm has a market cap of $6.91 billion, a PE ratio of 28.60 and a beta of 0.27.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Thursday, July 28th. The company reported $1.18 EPS for the quarter, hitting the Zacks’ consensus estimate of $1.18. Stericycle had a return on equity of 14.84% and a net margin of 7.22%. The firm earned $891.60 million during the quarter, compared to analyst estimates of $910.29 million. During the same period last year, the company posted $1.14 EPS. The business’s quarterly revenue was up 24.6% compared to the same quarter last year. Equities analysts expect that Stericycle Inc. will post $4.67 EPS for the current fiscal year.
A number of research firms have recently commented on SRCL. Macquarie started coverage on shares of Stericycle in a research note on Thursday, August 25th. They set a “neutral” rating and a $96.00 price objective for the company. Jefferies Group reissued a “buy” rating and set a $112.50 target price (down previously from $125.00) on shares of Stericycle in a research report on Wednesday, September 7th. Zacks Investment Research raised shares of Stericycle from a “sell” rating to a “hold” rating in a research report on Monday, July 4th. Imperial Capital downgraded shares of Stericycle from an “in-line” rating to an “underperform” rating and dropped their target price for the stock from $100.00 to $93.50 in a research report on Friday, July 29th. Finally, Wellington Shields downgraded shares of Stericycle from an “accumulate” rating to a “hold” rating in a research report on Friday, July 29th. Two equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and three have assigned a buy rating to the company’s stock. Stericycle presently has an average rating of “Hold” and a consensus target price of $115.55.
In other news, Director Rodney F. Dammeyer sold 10,188 shares of the firm’s stock in a transaction dated Wednesday, August 17th. The stock was sold at an average price of $85.50, for a total transaction of $871,074.00. Following the completion of the sale, the director now directly owns 10,188 shares of the company’s stock, valued at approximately $871,074. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Mark C. Miller sold 34,835 shares of the firm’s stock in a transaction dated Friday, July 8th. The stock was sold at an average price of $104.52, for a total value of $3,640,954.20. Following the sale, the director now directly owns 244,284 shares of the company’s stock, valued at $25,532,563.68. The disclosure for this sale can be found here. Insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider with a focus on regulated and compliance solutions for healthcare, retail and commercial businesses. The Company’s solutions include the collection and processing of specialized waste for disposal, the collection of personal and confidential information for secure destruction, and a range of training, consulting, recall/return, communication and compliance services.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc. (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.